You are here

Viekira Pak

How AbbVie Could Hammer Gilead's Hepatitis C Franchise

How AbbVie Could Hammer Gilead's Hepatitis C Franchise

Investors Business Daily

Gilead Sciences

Flag link:

3 Biggest Risks for AbbVie in 2017

3 Biggest Risks for AbbVie in 2017

Motley Fool

Flag link:

3 Things AbbVie's Management Said While Its Stock Got Hammered

3 Things AbbVie's Management Said While Its Stock Got Hammered

Motley Fool

Flag link:

AbbVie's Viekira Pak Sales Plummet in Q3

AbbVie's Viekira Pak Sales Plummet in Q3

Motley Fool

Flag link:

AbbVie Inc: New Drugs May Overcome Humira Loss

AbbVie Inc: New Drugs May Overcome Humira Loss

Bidness, ETC

Flag link:

AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis

AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis

Yahoo

Flag link:

Will Merck Encroach On Gilead's Harvoni Territory?

Will Merck Encroach On Gilead's Harvoni Territory?

Yahoo/Benzinga

Flag link:

Harvoni’s New Label Gives Gilead Edge Over AbbVie

Harvoni’s New Label Gives Gilead Edge Over AbbVie

Bidness, ETC

Gilead Sciences

Flag link:

3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next

3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next

Motley Fool

Flag link:

AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15

AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15

Yahoo/Market Realist

Flag link:

AbbVie's Management Just Made Some Pretty Bold Predictions

AbbVie's Management Just Made Some Pretty Bold Predictions

Motley Fool

Flag link:

Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up

Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up

Bidness, ETC

Gilead Sciences

Flag link:

Is Merck & Co. About to Derail Gilead Sciences?

Is Merck & Co. About to Derail Gilead Sciences?

Motley Fool

Gilead Sciences

grazoprevir/elbasvir

Flag link:

AbbVie Announces FDA Acceptance of New Drug Application for a Once-Daily Formulation of VIEKIRA PAK to Treat Genotype 1 Chronic Hepatitis C Virus Infection

AbbVie Announces FDA Acceptance of New Drug Application for a Once-Daily Formulation of VIEKIRA PAK to Treat Genotype 1 Chronic Hepatitis C Virus Infection

Yahoo

Flag link:

AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis

AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis

Yahoo

Flag link:

Express Scripts to maintain availability of AbbVie's hep C drug

Express Scripts to maintain availability of AbbVie's hep C drug

Yahoo/Reuters

Express Scripts

Flag link:

FDA's Warning Shakes Up Hep C Landscape

FDA's Warning Shakes Up Hep C Landscape

Investopedia

Gilead Sciences

Flag link:

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

24/7 Wall St

Gilead Sciences

Flag link:

FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%

FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%

Fierce Pharma

Flag link:

Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?

Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?

Motley Fool

Gilead Sciences

Flag link:

Pages